What You Need To Know About The Use Of Tofacitinib In Rheumatoid Arthritis

Speciality: Rheumatology

Description:

A warm welcome to all the medical professionals in this interesting session of efficacy and safety of JAK inhibitor drugs tofacitinib in rheumatoid arthritis. We have Dr. Sundeep Upadhyaya, Dr. Sonal Mehra, Dr. Chanchal Gera to lead the session.

Immunological pathways play a crucial role in rheumatic disease management. Managing rheumatoid arthritis often becomes difficult due to its rate of progression and associated health issues. 

The webinar will help in gaining important insights on the efficacy and safety of JAK inhibiting drugs like tofacitinib in controlling rheumatoid arthritis. Tofacitinib inhibits the process of intracellular signaling from the receptor to the cellular nucleus and inhibits the inflammation process via inhibition of the Janus kinases.

Data from the clinical trials have suggested the use of JAK inhibitors like tofacitinib has much lower risk of infection or other side effects compared to TNF inhibitors. Learn more about the safety of tofacitinib from this session. 

Therefore, listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
 

See More Webinars @ Hidoc Webinars